ICU Medical Inc/de (ICUI) · Insider trading

What ICU Medical Inc/de's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.

Bought, 12 months

0 insiders, 0 trades

Sold, 12 months

$8.27M

7 insiders, 43% under a plan

Net, 12 months

−$8.27M

bought less sold

Latest filing

2026-09-03

filings read to 2026-10-19

Bought and sold at the market, by month

Two years. Purchases above the line, sales below, in dollars.

Bought Sold Largest month: $7.70M

Who traded, two years

Insider	Bought	Sold	Trades	Last trade	Holds after
Voigtlander Christian B.Chief Operating Officer	–	$10.39M	15	2026-08-11	37,377
Jain VivekDirector, Chairman and CEO	$2.47M	$4.23M	10	2025-08-14	110,598
Bonnell Brian MichaelChief Financial Officer	–	$2.72M	5	2026-09-01	56,062
Woolson DanielVP, GM-Infusion Capital	–	$2.05M	4	2026-08-13	17,062
Sanzone Virginia RuthVP, General Counsel	–	$1.35M	7	2026-09-03	17,258
Greenberg David C.Director	$151,697	$730,604	5	2026-05-12	7,960
Sousa BenChief Information Officer	–	$675,940	2	2026-08-12	3,076
Finney Elisha WDirector	–	$332,769	3	2026-08-11	4,871

Open-market purchases and sales

Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.

Date	Insider	Trade	Shares	Price	Value	Holds after	Filing
2026-09-03	Sanzone Virginia RuthVP, General Counsel	Saleplan	2,202	167.67	$369,209	17,258	Form 4
2026-09-03	Sanzone Virginia RuthVP, General Counsel	Saleplan	1,238	168.44	$208,529	16,020	Form 4
2026-09-03	Sanzone Virginia RuthVP, General Counsel	Saleplan	724	169.53	$122,740	15,296	Form 4
2026-09-03	Sanzone Virginia RuthVP, General Counsel	Saleplan	692	171.52	$118,692	14,604	Form 4
2026-09-01	Bonnell Brian MichaelChief Financial Officer	Saleplan	6,381	175.00	$1.12M	56,062	Form 4
2026-08-31	Bonnell Brian MichaelChief Financial Officer	Saleplan	1,712	171.05	$292,838	70,038	Form 4
2026-08-31	Bonnell Brian MichaelChief Financial Officer	Saleplan	1,914	172.12	$329,438	68,124	Form 4
2026-08-31	Bonnell Brian MichaelChief Financial Officer	Saleplan	4,568	173.44	$792,274	63,556	Form 4
2026-08-31	Bonnell Brian MichaelChief Financial Officer	Saleplan	1,113	173.91	$193,562	62,443	Form 4
2026-08-13	Woolson DanielVP, GM-Infusion Capital	Sale	5,417	181.33	$982,265	17,062	Form 4
2026-08-12	Sousa BenChief Information Officer	Sale	2,250	178.32	$401,220	3,076	Form 4
2026-08-11	Finney Elisha WDirector	Sale	378	182.48	$68,977	4,871	Form 4
2026-08-11	Voigtlander Christian B.Chief Operating Officer	Sale	8,929	182.93	$1.63M	37,377	Form 4
2026-05-22	Woolson DanielPresident	Sale	2,123	132.21	$280,682	22,479	Form 4
2026-05-14	Sanzone Virginia RuthVP, General Counsel	Sale	2,447	124.08	$303,624	19,460	Form 4
2026-05-12	Greenberg David C.Director	Sale	2,424	122.91	$297,934	7,960	Form 4
2025-11-25	Woolson DanielVP, GM-Infusion Capital	Sale	2,897	152.35	$441,358	11,297	Form 4
2025-11-11	Finney Elisha WDirector	Sale	1,285	140.42	$180,440	3,995	Form 4
2025-11-11	Sanzone Virginia RuthVP, General Counsel	Sale	930	142.35	$132,386	5,456	Form 4
2025-08-27	Greenberg David C.Director	Buy	602	126.14	$75,936	7,362	Form 4
2025-08-27	Greenberg David C.Director	Buy	598	126.69	$75,761	7,960	Form 4
2025-08-14	Jain VivekDirector, Chairman and CEO	Buy	2,378	112.12	$266,621	110,598	Form 4
2025-08-14	Jain VivekDirector, Chairman and CEO	Buy	19,551	112.92	$2.21M	130,149	Form 4
2025-05-30	Sanzone Virginia RuthVP, General Counsel	Sale	700	133.62	$93,534	6,386	Form 4
2025-05-28	Voigtlander Christian B.Chief Operating Officer	Sale	4,985	128.50	$640,572	6,088	Form 4
2025-05-27	Voigtlander Christian B.Chief Operating Officer	Sale	4,945	131.00	$647,795	5,513	Form 4
2025-05-23	Voigtlander Christian B.Chief Operating Officer	Sale	4,959	130.00	$644,670	4,903	Form 4
2025-05-22	Voigtlander Christian B.Chief Operating Officer	Sale	4,959	130.03	$644,819	4,307	Form 4
2025-05-21	Voigtlander Christian B.Chief Operating Officer	Sale	4,917	133.00	$653,961	3,711	Form 4
2025-05-20	Voigtlander Christian B.Chief Operating Officer	Sale	4,871	137.11	$667,863	3,073	Form 4
2025-05-19	Finney Elisha WDirector	Sale	600	138.92	$83,352	3,252	Form 4
2025-05-19	Voigtlander Christian B.Chief Operating Officer	Sale	5,555	138.00	$766,590	2,389	Form 4
2025-05-16	Voigtlander Christian B.Chief Operating Officer	Sale	5,555	140.00	$777,700	2,389	Form 4
2025-05-15	Voigtlander Christian B.Chief Operating Officer	Sale	5,555	135.55	$752,980	2,389	Form 4
2025-05-15	Sousa BenChief Information Officer	Sale	2,000	137.36	$274,720	479	Form 4
2025-05-14	Voigtlander Christian B.Chief Operating Officer	Sale	5,556	138.65	$770,339	2,389	Form 4
2025-05-13	Greenberg David C.Director	Sale	1,942	143.66	$278,988	6,760	Form 4
2025-01-02	Jain VivekDirector, Chairman and CEO	Saleplan	1,373	155.48	$213,474	104,593	Form 4
2024-12-06	Woolson DanielVP, GM-Infusion Capital	Sale	2,241	156.25	$350,156	10,866	Form 4
2024-12-02	Jain VivekDirector, Chairman and CEO	Saleplan	3,672	162.29	$595,929	112,921	Form 4

11 more

2024-12-02	Jain VivekDirector, Chairman and CEO	Saleplan	8,250	163.18	$1.35M	104,671	Form 4
2024-12-02	Jain VivekDirector, Chairman and CEO	Saleplan	78	163.96	$12,789	104,593	Form 4
2024-11-27	Greenberg David C.Director	Sale	972	158.11	$153,683	5,037	Form 4
2024-11-27	Voigtlander Christian B.Chief Operating Officer	Sale	1,430	158.00	$225,940	0	Form 4
2024-11-26	Voigtlander Christian B.Chief Operating Officer	Sale	7,513	159.09	$1.20M	206	Form 4
2024-11-26	Voigtlander Christian B.Chief Operating Officer	Sale	206	160.09	$32,979	0	Form 4
2024-11-25	Voigtlander Christian B.Chief Operating Officer	Sale	1,962	169.08	$331,735	0	Form 4
2024-11-01	Jain VivekDirector, Chairman and CEO	Saleplan	4,228	170.75	$721,931	112,365	Form 4
2024-11-01	Jain VivekDirector, Chairman and CEO	Saleplan	4,147	171.91	$712,911	108,218	Form 4
2024-11-01	Jain VivekDirector, Chairman and CEO	Saleplan	2,386	172.76	$412,205	105,832	Form 4
2024-11-01	Jain VivekDirector, Chairman and CEO	Saleplan	1,239	173.60	$215,090	104,593	Form 4

Grants, exercises and other transactions

Pay, tax and paperwork rather than a choice to trade at the market price. Two years.

72 × option exercise38 × shares withheld for tax2 × gift1 × other

Show them

Date	Insider	What	Shares	Price	Holds after	Filing
2026-05-13	Finney Elisha WDirector	Option exercise M	+1,254	–	5,249	Form 4
2026-05-13	Hoffmeister David FDirector	Option exercise M	+1,254	–	6,004	Form 4
2026-05-13	Kennedy Kolleen TDirector	Option exercise M	+1,254	–	4,539	Form 4
2026-05-13	Abbey DonaldDirector	Option exercise M	+1,254	–	6,004	Form 4
2026-05-13	Greenberg David C.Director	Option exercise M	+1,254	–	9,214	Form 4
2026-05-13	Hernandez LaurieDirector	Option exercise M	+1,254	–	4,862	Form 4
2026-05-12	Greenberg David C.Director	Option exercise M	+2,424	101.06	10,384	Form 4
2026-03-25	Abbey DonaldDirector	Other J	−704	–	4,046	Form 4
2026-03-15	Jain VivekDirector, Chairman and CEO	Option exercise M	+17,100	–	134,106	Form 4
2026-03-15	Jain VivekDirector, Chairman and CEO	Shares withheld for tax F	−9,452	125.85	124,654	Form 4
2026-03-15	Jain VivekDirector, Chairman and CEO	Option exercise M	+4,872	–	129,526	Form 4
2026-03-15	Jain VivekDirector, Chairman and CEO	Shares withheld for tax F	−2,693	125.85	126,833	Form 4
2026-03-15	Sanzone Virginia RuthVP, General Counsel	Option exercise M	+5,700	–	24,330	Form 4
2026-03-15	Sanzone Virginia RuthVP, General Counsel	Shares withheld for tax F	−3,150	125.85	21,180	Form 4
2026-03-15	Sanzone Virginia RuthVP, General Counsel	Option exercise M	+1,624	–	22,804	Form 4
2026-03-15	Sanzone Virginia RuthVP, General Counsel	Shares withheld for tax F	−897	125.85	21,907	Form 4
2026-03-15	Woolson DanielVP, GM-Infusion Capital	Option exercise M	+2,924	–	25,897	Form 4
2026-03-15	Woolson DanielVP, GM-Infusion Capital	Shares withheld for tax F	−1,295	125.85	24,602	Form 4
2026-03-15	Voigtlander Christian B.Chief Operating Officer	Option exercise M	+11,400	–	51,154	Form 4
2026-03-15	Voigtlander Christian B.Chief Operating Officer	Shares withheld for tax F	−6,301	125.85	44,853	Form 4
2026-03-15	Voigtlander Christian B.Chief Operating Officer	Option exercise M	+3,248	–	48,101	Form 4
2026-03-15	Voigtlander Christian B.Chief Operating Officer	Shares withheld for tax F	−1,795	125.85	46,306	Form 4
2026-03-15	Bonnell Brian MichaelChief Financial Officer	Option exercise M	+11,400	–	76,097	Form 4
2026-03-15	Bonnell Brian MichaelChief Financial Officer	Shares withheld for tax F	−5,800	125.85	70,297	Form 4
2026-03-15	Bonnell Brian MichaelChief Financial Officer	Option exercise M	+3,248	–	73,545	Form 4
2026-03-15	Bonnell Brian MichaelChief Financial Officer	Shares withheld for tax F	−1,795	125.85	71,750	Form 4
2026-03-15	Sousa BenChief Information Officer	Option exercise M	+1,300	–	6,044	Form 4
2026-03-15	Sousa BenChief Information Officer	Shares withheld for tax F	−718	125.85	5,326	Form 4
2026-03-08	Jain VivekDirector, Chairman and CEO	Option exercise M	+107,635	–	176,506	Form 4
2026-03-08	Jain VivekDirector, Chairman and CEO	Shares withheld for tax F	−59,500	132.00	117,006	Form 4
2026-03-08	Sanzone Virginia RuthVP, General Counsel	Option exercise M	+23,917	–	30,424	Form 4
2026-03-08	Sanzone Virginia RuthVP, General Counsel	Shares withheld for tax F	−13,221	132.00	17,203	Form 4
2026-03-08	Sanzone Virginia RuthVP, General Counsel	Option exercise M	+3,189	–	20,392	Form 4
2026-03-08	Sanzone Virginia RuthVP, General Counsel	Shares withheld for tax F	−1,762	132.00	18,630	Form 4
2026-03-08	Woolson DanielVP, GM-Infusion Capital	Option exercise M	+16,147	–	28,327	Form 4
2026-03-08	Woolson DanielVP, GM-Infusion Capital	Shares withheld for tax F	−6,877	132.00	21,450	Form 4
2026-03-08	Woolson DanielVP, GM-Infusion Capital	Option exercise M	+2,153	–	23,603	Form 4
2026-03-08	Woolson DanielVP, GM-Infusion Capital	Shares withheld for tax F	−630	132.00	22,973	Form 4
2026-03-08	Voigtlander Christian B.Chief Operating Officer	Option exercise M	+71,757	–	79,421	Form 4
2026-03-08	Voigtlander Christian B.Chief Operating Officer	Shares withheld for tax F	−39,667	132.00	39,754	Form 4
2026-03-08	Bonnell Brian MichaelChief Financial Officer	Option exercise M	+71,757	–	104,364	Form 4
2026-03-08	Bonnell Brian MichaelChief Financial Officer	Shares withheld for tax F	−39,667	132.00	64,697	Form 4
2026-03-08	Sousa BenChief Information Officer	Option exercise M	+7,177	–	8,283	Form 4
2026-03-08	Sousa BenChief Information Officer	Shares withheld for tax F	−3,967	132.00	4,316	Form 4
2026-03-08	Sousa BenChief Information Officer	Option exercise M	+957	–	5,273	Form 4
2026-03-08	Sousa BenChief Information Officer	Shares withheld for tax F	−529	132.00	4,744	Form 4
2026-03-07	Jain VivekDirector, Chairman and CEO	Option exercise M	+5,282	–	71,790	Form 4
2026-03-07	Jain VivekDirector, Chairman and CEO	Shares withheld for tax F	−2,919	–	68,871	Form 4
2026-03-07	Sanzone Virginia RuthVP, General Counsel	Option exercise M	+2,348	–	7,804	Form 4
2026-03-07	Sanzone Virginia RuthVP, General Counsel	Shares withheld for tax F	−1,297	132.00	6,507	Form 4
2026-03-07	Woolson DanielVP, GM-Infusion Capital	Option exercise M	+1,585	–	12,882	Form 4
2026-03-07	Woolson DanielVP, GM-Infusion Capital	Shares withheld for tax F	−702	132.00	12,180	Form 4
2026-03-07	Voigtlander Christian B.Chief Operating Officer	Option exercise M	+3,522	–	9,610	Form 4
2026-03-07	Voigtlander Christian B.Chief Operating Officer	Shares withheld for tax F	−1,946	132.00	7,664	Form 4
2026-03-07	Bonnell Brian MichaelChief Financial Officer	Option exercise M	+3,522	–	33,870	Form 4
2026-03-07	Bonnell Brian MichaelChief Financial Officer	Shares withheld for tax F	−1,263	–	32,607	Form 4
2026-03-07	Sousa BenChief Information Officer	Option exercise M	+1,409	–	1,888	Form 4
2026-03-07	Sousa BenChief Information Officer	Shares withheld for tax F	−782	132.00	1,106	Form 4
2025-11-11	Finney Elisha WDirector	Option exercise M	+1,285	103.76	5,280	Form 4
2025-09-12	Jain VivekDirector, Chairman and CEO	Gift G	−63,641	–	66,508	Form 4
2025-09-12	Jain VivekDirector, Chairman and CEO	Gift G	+63,641	–	152,339	Form 4
2025-05-28	Voigtlander Christian B.Chief Operating Officer	Option exercise M	+5,560	96.83	11,073	Form 4
2025-05-27	Voigtlander Christian B.Chief Operating Officer	Option exercise M	+5,555	96.83	10,458	Form 4
2025-05-23	Voigtlander Christian B.Chief Operating Officer	Option exercise M	+5,555	96.83	9,862	Form 4
2025-05-22	Voigtlander Christian B.Chief Operating Officer	Option exercise M	+5,555	96.83	9,266	Form 4
2025-05-21	Voigtlander Christian B.Chief Operating Officer	Option exercise M	+5,555	96.83	8,628	Form 4
2025-05-20	Voigtlander Christian B.Chief Operating Officer	Option exercise M	+5,555	96.83	7,944	Form 4
2025-05-19	Voigtlander Christian B.Chief Operating Officer	Option exercise M	+5,555	96.83	7,944	Form 4
2025-05-16	Voigtlander Christian B.Chief Operating Officer	Option exercise M	+5,555	96.83	7,944	Form 4
2025-05-15	Voigtlander Christian B.Chief Operating Officer	Option exercise M	+5,555	96.83	7,944	Form 4
2025-05-14	Voigtlander Christian B.Chief Operating Officer	Option exercise M	+5,556	96.83	7,945	Form 4
2025-05-13	Finney Elisha WDirector	Option exercise M	+1,723	–	3,852	Form 4
2025-05-13	Abbey DonaldDirector	Option exercise M	+1,723	–	4,750	Form 4
2025-05-13	Hoffmeister David FDirector	Option exercise M	+1,723	–	4,750	Form 4
2025-05-13	Kennedy Kolleen TDirector	Option exercise M	+1,723	–	3,285	Form 4
2025-05-13	Greenberg David C.Director	Option exercise M	+1,723	–	6,760	Form 4
2025-05-13	Greenberg David C.Director	Option exercise M	+1,942	94.68	8,702	Form 4
2025-05-13	Hernandez LaurieDirector	Option exercise M	+1,723	–	3,608	Form 4
2025-03-15	Jain VivekDirector, Chairman and CEO	Option exercise M	+4,872	–	110,908	Form 4
2025-03-15	Jain VivekDirector, Chairman and CEO	Shares withheld for tax F	−2,688	143.45	108,220	Form 4
2025-03-15	Sanzone Virginia RuthVP, General Counsel	Option exercise M	+1,624	–	7,984	Form 4
2025-03-15	Sanzone Virginia RuthVP, General Counsel	Shares withheld for tax F	−898	143.45	7,086	Form 4
2025-03-15	Woolson DanielVP, GM-Infusion Capital	Option exercise M	+2,923	–	15,488	Form 4
2025-03-15	Woolson DanielVP, GM-Infusion Capital	Shares withheld for tax F	−1,294	143.45	14,194	Form 4
2025-03-15	Voigtlander Christian B.Chief Operating Officer	Option exercise M	+3,248	–	4,181	Form 4
2025-03-15	Voigtlander Christian B.Chief Operating Officer	Shares withheld for tax F	−1,792	143.45	2,389	Form 4
2025-03-15	Bonnell Brian MichaelChief Financial Officer	Option exercise M	+3,248	–	30,348	Form 4
2025-03-15	Sousa BenChief Information Officer	Option exercise M	+1,299	–	3,195	Form 4
2025-03-15	Sousa BenChief Information Officer	Shares withheld for tax F	−716	143.45	2,479	Form 4
2025-03-08	Sanzone Virginia RuthVP, General Counsel	Option exercise M	+3,189	–	8,119	Form 4
2025-03-08	Sanzone Virginia RuthVP, General Counsel	Shares withheld for tax F	−1,759	141.97	6,360	Form 4
2025-03-08	Woolson DanielVP, GM-Infusion Capital	Option exercise M	+2,153	–	13,518	Form 4
2025-03-08	Woolson DanielVP, GM-Infusion Capital	Shares withheld for tax F	−953	141.97	12,565	Form 4
2025-03-08	Sousa BenChief Information Officer	Option exercise M	+957	–	2,446	Form 4
2025-03-08	Sousa BenChief Information Officer	Shares withheld for tax F	−550	141.97	1,896	Form 4
2025-03-07	Jain VivekDirector, Chairman and CEO	Shares withheld for tax F	−1,775	–	102,818	Form 4
2025-03-07	Jain VivekDirector, Chairman and CEO	Option exercise M	+3,218	–	106,036	Form 4
2025-03-07	Sanzone Virginia RuthVP, General Counsel	Option exercise M	+1,073	–	5,555	Form 4
2025-03-07	Sanzone Virginia RuthVP, General Counsel	Shares withheld for tax F	−625	141.97	4,930	Form 4
2025-03-07	Woolson DanielVP, GM-Infusion Capital	Option exercise M	+966	–	11,832	Form 4
2025-03-07	Woolson DanielVP, GM-Infusion Capital	Shares withheld for tax F	−467	141.97	11,365	Form 4
2025-03-07	Voigtlander Christian B.Chief Operating Officer	Option exercise M	+2,146	–	2,146	Form 4
2025-03-07	Voigtlander Christian B.Chief Operating Officer	Shares withheld for tax F	−1,213	141.97	933	Form 4
2025-03-07	Bonnell Brian MichaelChief Financial Officer	Option exercise M	+2,146	–	27,100	Form 4
2025-03-07	Sousa BenChief Information Officer	Option exercise M	+430	–	1,749	Form 4
2025-03-07	Sousa BenChief Information Officer	Shares withheld for tax F	−260	141.97	1,489	Form 4
2025-01-02	Jain VivekDirector, Chairman and CEO	Option exercise M	+1,373	88.76	105,966	Form 4
2024-12-02	Jain VivekDirector, Chairman and CEO	Option exercise M	+12,000	88.76	116,593	Form 4
2024-11-27	Greenberg David C.Director	Option exercise M	+972	94.68	6,009	Form 4
2024-11-27	Voigtlander Christian B.Chief Operating Officer	Option exercise M	+1,430	96.83	1,430	Form 4
2024-11-26	Voigtlander Christian B.Chief Operating Officer	Option exercise M	+7,719	96.83	7,719	Form 4
2024-11-25	Voigtlander Christian B.Chief Operating Officer	Option exercise M	+1,962	96.83	1,962	Form 4
2024-11-01	Jain VivekDirector, Chairman and CEO	Option exercise M	+12,000	88.76	116,593	Form 4

How to read it

Buy, sale: Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
Plan: A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
Holds after: The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
Value: Shares times the price the form reports, which is often an average over several fills on the day.

Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.

ICU Medical Inc/de's scores and multiples ›